Overweight and obese people in the Asia-Pacific region are at increased risk of certain types of cancer fatalities, investigators reported June 30 in the Lancet Oncology.
Cardiopulmonary exercise testing offers the clinician the ability to obtain a wealth of information beyond the standard exercise ECG testing but is underused and underappreciated today, a panel of experts said in a clinicians and scientific statement released June 28 by the American Heart Association.
nce-weekly exenatide reduced hemoglobin A to a significantly greater degree than did either sitagliptin or pioglitazone in DURATION-2, a 26-week randomized, double-blind trial of 491 patients with type 2 diabetes who had baseline HbA levels of 8.5% or higher despite metformin treatment.
Dapagliflozin significantly reduced hemoglobin A levels compared with placebo in a phase III, multicenter, randomized, double-blind, placebo-controlled trial involving 534 patients with type 2 diabetes inadequately controlled with metformin alone.
Fractional rather than full doses of inactivated polio vaccine, given intradermally with a jet injector rather than a needle, produced seroconversion rates comparable to those achieved with full-dose vaccine injected intramuscularly, according to a study in the June 24 issue of the New England Journal of Medicine.
Weight gain and fat accumulation in both middle and older age raise the risk of diabetes, according to a prospective cohort study reported in the June 23/30 issue of JAMA.
Pfizer Inc. announced June 21 it is voluntarily withdrawing the anti-CD33 monoclonal antibody gemtuzumab ozogamicin from the U.S. market as of October 15, 2010.
GAITHERSBURG, Md. (EGMN) A Food and Drug Administration advisory panel on June 18 unanimously agreed that concerns about the risks of flibanserin outweighed any evidence that the drug was effective as a treatment for premenopausal women with hypoactive sexual desire disorder.
GAITHERSBURG, Md. (EGMN) Food and Drug Administration advisory panel on June 17 unanimously agreed that the selective progesterone receptor modulator ulipristal acetate is an effective emergency contraceptive with an acceptable safety profile, when used within 5 days of unprotected intercourse or a known or suspected contraceptive failure.
